About Welshare Health
Welshare Health is developing a health profile matchmaking protocol (HPMP) that matches AI agent researchers with patients to accelerate medical breakthroughs.
Our mission is to empower individuals to control, contribute, and benefit from their health data, while building the decentralized infrastructure for AI-driven scientific breakthroughs.
By leveraging the decentralized nature of blockchain and the analytical power of AI, we aim to revolutionize the way medical research is conducted and healthcare is delivered.
Our Vision
We envision a future where individuals become active contributors to "Agentic Research" — AI agents working alongside users to validate hypotheses and generate scientific breakthroughs. Users remain "in the loop," maintaining control over their data and intellectual property.
Our vision is to create a world where everyone can actively participate in advancing medical knowledge and improving healthcare outcomes. By harnessing the collective power of individuals' health data, we aim to accelerate scientific discoveries, personalize healthcare interventions, and empower individuals to take control of their health journey.
The Problem
Agentic AI researchers need a conversational "Patient-in-the-loop" to verify their research hypotheses.
Medical research today is slow, expensive, and disconnected from patients:
- $600 billion lost annually due to lack of patient behavior insights.
- 75% of patients want more personalized healthcare.
- 74% of patients are willing to share their data if it improves healthcare.
However, researchers (and now AI agents) need ways to access real-world patient data safely, consentfully, and at scale — something traditional health systems are ill-equipped to support.
The Solution
The Health Profile Matching Protocol (HPMP) enables agents to discover user profiles and establish bidirectional communication channels.
The Health Profile Matching Protocol (HPMP) is a decentralized infrastructure designed to connect agentic researchers with users who own and control their health data. HPMP enables secure, privacy-preserving discovery and interaction between AI agents and human participants.
Now AI agent researchers can query the protocol for correlations and insights, open bidirectional communication channels with users, and ask users to share more data points or answer surveys.
Protocol Landscape
The HPMP safely stores and computes over user profile data, is accessed via SDKs and MCP, and manages communication channels.
Research Flywheel
The HPMP enables a self-reinforcing cycle of expanding research knowledge that ultimately improves personalized health services for patients.
Market Size
The $600 billion market for clinical trials and patient behavior insights is ripe for disruption.
Why web3
Web3 technology enables this medical research contribution in a way that previously was not possible. In particular, leveraging web3 enables secure data processing, ownership & monetization, and confidential compute.
DeSci x AI
At the core of Welshare Health lies the fusion of Decentralized Science (DeSci) and AI. DeSci enables the democratization of medical research by decentralizing data ownership and incentivizing individuals to contribute their health data securely. AI augments this process by analyzing vast amounts of anonymized health data to uncover valuable insights and accelerate medical discoveries.
DeSci
DeSci fundamentally shifts the paradigm of medical research by empowering individuals to have ownership and control over their health data. Traditional medical research often faces barriers due to centralized control of data, leading to limited access and insights. By leveraging blockchain technology, DeSci ensures data security, privacy, and transparency while allowing users to contribute their data willingly.
AI
AI plays a pivotal role in enhancing the capabilities of Welshare Health's decentralized ecosystem. By harnessing the power of machine learning algorithms, AI sifts through vast datasets collected from diverse sources, identifying patterns, correlations, and predictive models that may elude human analysis. This enables researchers to gain deeper insights into disease mechanisms, treatment efficacy, and personalized healthcare interventions.
A Real-World Application of DeSci x AI in Diabetes
We know people often throw the word "AI" around carelessly, so let's be specific and solve a real-world problem.
In the realm of diabetes management, individuals living with type 1 diabetes (T1D) face a persistent challenge: the fluctuating nature of blood glucose levels and the constant need for precise insulin dosing.
In type 1 diabetes, the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas, leading to an inability to produce insulin—a hormone essential for regulating blood sugar levels. Without insulin, glucose levels in the blood can rise to dangerous levels, causing a range of acute and chronic complications, including cardiovascular disease, kidney failure, nerve damage, and vision problems.
Insulin therapy is the cornerstone of type 1 diabetes management, aimed at replacing the deficient insulin and keeping blood glucose within a healthy range. However, achieving optimal glycemic control with manual insulin administration is a complex and demanding task. Factors such as diet, physical activity, stress, illness, and hormonal fluctuations can all influence blood glucose levels, requiring frequent adjustments in insulin dosage throughout the day.
AID systems offer a transformative solution by automating aspects of insulin delivery and glucose monitoring. These systems typically consist of a continuous glucose monitor (CGM) to measure glucose levels in real time and an insulin pump to deliver insulin doses as needed. By integrating these components with sophisticated algorithms, AID systems can adjust insulin delivery in response to changing glucose levels, mimicking the function of a healthy pancreas more closely.
However, existing AID systems often lack the level of personalization needed to effectively address the diverse physiological and lifestyle factors influencing blood glucose dynamics (such as dietary patterns, physical activity, stress levels, sleep patterns, alcohol consumption, medications, illnesses and infections). As a result, patients may struggle to achieve stable glycemic control, leading to frustration, anxiety, and an increased burden of disease management.
In this context, the integration of Artificial Intelligence (AI) holds immense promise, offering a pathway towards the development of hyper-personalized algorithms capable of revolutionizing AID technology by personalizing insulin delivery, implementing predictive analytics, leveraging adaptive learning and integrating other components (such as wearables) of the broader digital health ecosystem, hence transforming the lives of individuals living with diabetes.
The synergy between DeSci and AI within Welshare Health's solution creates a dynamic ecosystem where individuals are not merely passive data contributors but active participants in advancing medical knowledge. Through decentralized governance mechanisms and smart contracts, users are incentivized to share their data ethically and responsibly, ensuring a fair and equitable distribution of rewards. Additionally, AI-driven insights empower users to make informed decisions about their health, driving proactive engagement in preventive care and disease management.
Tokenomics
WEL is an ERC-20 token that is a currency token.
Total Supply
There is a limited Total Supply of 2,500,000,000 WEL.
Token Allocation
Vesting Schedules
Founders and team receive 0% at TGE and are subject to a 6-month cliff, then 5-year vesting.
Advisors receive 0% at TGE and are subject to a 3-month cliff, then 5-year vesting.
Private Pre-Sale
4% of the token supply is allocated for the private pre-sale at a price of $0.002. Private pre-sale participants receive 10% at TGE and are subject to a 3-month cliff, then 24-month vesting.
Private Pre-Sale price: $0.002
Public Pre-Sale
10% of the token supply will be sold via the public pre-sale process.
There will be 3 phases.
Phase 1 price: $0.004
Phase 2 price: $0.005
Phase 3 price: $0.006
Public pre-sale participants receive 20% at TGE and are subject to a 1-month cliff, then 6-month vesting.
How to Buy WEL
Note: Due to regulatory restrictions, US persons are prohibited from acquiring the WEL token (see Legal Details below).
For non-US persons, you can purchase the WEL token on Uniswap at: https://app.uniswap.org/explore/tokens/ethereum/0x1e762e1fac176bbb341656035daf5601b1c69be5
Token contract address: 0x1E762e1FAc176bbB341656035daf5601b1C69Be5
All pre-sales have ended. TGE is on Oct. 23.
Public Pre-Sales: How to claim your $WEL tokens
If you have purchased $WEL vouchers and passed the KYC process, the following applies to you:
On Oct. 23rd, you will be able to claim your $WEL tokens.
Vesting is set up with Sablier, an industry-standard vesting tool. (https://sablier.com/)
Sablier creates an airstream that you need to claim. An airstream is similar to an airdrop but instead of being transferred instantaneously it can be "streamed" over a given period of time, thus enabling the functionality of vesting.
How do you claim your $WEL tokens?
WATCH THIS VIDEO: https://www.youtube.com/watch?v=-QFLZtUQ330
PART 1: Claiming the airstream
Step 1: Go to https://app.sablier.com/airstreams/?t=eligible and sign in with your wallet.
Step 2: Check your eligibility by clicking on the magnifying glass icon and click on "Check".
Step 3: Click on "Claim" and validate the transaction in your wallet.
After claiming, Sablier will create the airstream for you. You will see the airstream in the Sablier dashboard.
PART 2: Withdrawing the tokens
Click on "Withdraw" and validate the transaction in your wallet.
For more details on Sablier airstreams, check their docs: https://docs.sablier.com/concepts/protocol/airstreams
Public Pre-Sales: Steps towards your WEL token application
- Purchase Vouchers: Important: Use the same wallet you log into the pre-sale page for your voucher purchase (on Juicebox). Note: These are not the WEL tokens. The WEL tokens will be distributed to people who are accepted to purchase. To apply, complete step 2.
- Apply for WEL Token: Follow the KYC process. You will need your ID and will be required to take a selfie.
Legal Details
Restrictions on Token Purchasers
The WEL token discussed here cannot be held by, offered, or sold to "U.S. persons" as defined by Rule 902 of Regulation S under the Securities Act of 1933, or within the United States. It is also prohibited to offer or sell the token, directly or indirectly, to U.S. persons or within the U.S.
Additionally, no entity, person, or corporate body, nor any affiliates or beneficial owners thereof, deemed a Prohibited Person, may own, buy, or sell the token. A "Prohibited Person" includes any individual or entity (government, political subdivision, agency, or instrumentality) that is: (i) a national or resident of, or entity formed under the laws of any U.S. embargoed or restricted country; (ii) a national or resident of, or entity formed under the laws of Cuba, North Korea, Iran, Libya, South Sudan, Sudan, Syria, or Crimea; (iii) listed on the U.S. Commerce Department's Denied Persons List, Entities List, or Unverified List; the Treasury's Specially Designated Nationals and Blocked Persons List, Specially Designated Narcotics Traffickers or Specially Designated Terrorists, or the Annex to Executive Order No. 13224; the State Department's Debarred List; or under UN Sanctions; (iv) restricted from business transactions by any U.S. Governmental Authority; or (v) subject to any economic sanctions enforced by the UN, EU, or UK.
Legal Disclaimer
PLEASE CONSULT YOUR LEGAL AND FINANCIAL ADVISORS BEFORE CONSIDERING PARTICIPATION IN THE TOKEN SALE.
Participation in the token sale does not equate to the exchange of cryptocurrencies for securities, investment units, or ordinary shares in any project, platform, company, or entity. The tokens issued and distributed are not intended to be securities or collective investment units in any entity. Token holders do not receive dividends or revenue rights and do not participate in any profit-sharing scheme.
Participants engage for their own account, not as nominees or agents, without the intention of reselling or distributing the tokens.
Participants have sufficient knowledge and experience in financial and business matters to evaluate the merits and risks of participation. They can incur a total loss without impairing their financial condition and can bear the economic risk for an indefinite period.
Participants affirm compliance with their jurisdiction's laws concerning token sale participation, including legal requirements, foreign exchange restrictions, necessary consents, and relevant tax consequences.
Participation and token holding must comply with applicable laws in the participant's jurisdiction.
Participants understand the significant risks involved, including potential failure of the network or tokens to function as intended, incomplete token launch or auction, insufficient user interest, and possible governmental investigation or punitive actions. Participants are financially sophisticated, capable of evaluating and bearing the risks, and have acquired sufficient information about Welshare Health to make an informed decision. Participants possess adequate technical understanding of cryptographic tokens, network protocols, smart contracts, token storage mechanisms, and distributed networks to appreciate the risks and implications.
THE PARTICIPANT ACKNOWLEDGES THAT THE INFORMATION PROVIDED IS SUFFICIENT FOR AN INFORMED DECISION AND CONFIRMS CONSULTATION WITH THEIR ATTORNEY, ACCOUNTANT, TAX ADVISOR, AND INVESTMENT ADVISOR.